European Heart Journal Advance Access published online on March 28, 2006
European Heart Journal, doi:10.1093/eurheartj/ehi851
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Unità di Ematologia e Trombosi, Ospedale San Paolo--Università di Milano, Via di Rudinì 8, 20142 Milano, Italy
* To whom correspondence should be addressed.
Editorial
P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents
Marco Cattaneo 1 *
Marco Cattaneo, E-mail: marco.cattaneo{at}unimi.it
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-P. Collet and G. Montalescot Review: Platelet Function Testing and Implications for Clinical Practice Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 157 - 169. [Abstract] [PDF] |
||||
![]() |
F. Van de Werf New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome? Eur. Heart J., July 2, 2009; 30(14): 1695 - 1702. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Newsome, R. S. Weller, J. C. Gerancher, M. A. Kutcher, and R. L. Royster Coronary Artery Stents: II. Perioperative Considerations and Management Anesth. Analg., August 1, 2008; 107(2): 570 - 590. [Abstract] [Full Text] [PDF] |
||||


